AXTI (AXTI) Q1 2024: Indium Phosphide Revenue Surges 48% on AI-Driven Demand Shift

May 2, 2024 | By EarningsIQ Research

AXTI’s Q1 revealed a decisive inflection in substrate demand, with indium phosphide revenue up 48% sequentially, propelled by AI data center applications and a meaningful shift in customer mix. Management’s Q2 guide signals further acceleration, while operational discipline and inventory strategy position the business for a potential return to profitability as legacy inventory clears. The evolving substrate mix and AI tailwind are reshaping AXTI’s revenue base and competitive posture heading into the second half.

Summary

  • AI Demand Rewires Substrate Mix: Indium phosphide’s resurgence is tied directly to high-speed optical and AI data center buildout.
  • Gallium Arsenide and Germanium Rebound: Both segments show sequential growth, broadening recovery beyond a single product line.
  • Inventory and Margin Leverage: Cost discipline and inventory reduction targets offer upside as volume and mix improve through 2024.

Business Overview

AXTI manufactures compound semiconductor substrates—indium phosphide, gallium arsenide, and germanium—used in high-performance optoelectronics, wireless, and solar applications. The company generates revenue from substrate sales to device manufacturers, as well as from its partially owned raw material joint ventures. Major product segments include indium phosphide (data centers, AI, photonics), gallium arsenide (power amplifiers, LEDs, lasers), and germanium (satellite solar cells). AXTI’s supply chain includes over ten JV companies, providing strategic control over input materials.

Performance Analysis

AXTI posted sequential and year-over-year revenue growth in Q1, with total revenue reaching $22.7 million, up from $20.4 million in Q4 and $19.4 million a year ago. The standout driver was indium phosphide, which increased 48% sequentially to $8.1 million, fueled by AI-related data center demand and a recovery in passive optical networks. Gallium arsenide also delivered a 24% sequential increase, broadening the recovery beyond a single catalyst. Germanium substrates rebounded 25% over Q4, reflecting renewed satellite solar cell demand.

Gross margin improved to 27.3% (non-GAAP), up from 23.2% in Q4, aided by better product mix and ongoing recycling program benefits. Operating expense rose to $8.7 million (non-GAAP) as management relaxed prior cost constraints to support demand, but OPEX is expected to remain at this level for the year. The company reported a non-GAAP net loss of $1.3 million, a substantial improvement over prior quarters. Cash declined to $41.3 million, primarily due to timing of receivables around Chinese New Year and catch-up CapEx payments. Inventory decreased by $0.6 million, with a stated goal of reducing it by $10 million over the year as demand strengthens and legacy stock is worked down.

  • Indium Phosphide AI Catalyst: AI-driven optical demand now accounts for as much as 20% of indium phosphide revenue, with new customer wins and accelerating order cycles.
  • Gallium Arsenide Cycle Turns: Broad-based application recovery, especially in automotive LEDs and power devices, signals supply chain normalization.
  • Germanium Recovery: Satellite solar cell demand is rebounding, particularly in Europe and Asia, after a weak 2023.

AXTI’s top five customers represented 33% of revenue, with one AI-related Epi House customer exceeding 10%, indicating a concentrated but evolving customer base. The company’s ability to flex inventory and cost structure remains a key lever as substrate demand shifts toward next-gen applications.

Executive Commentary

"We believe our business is on a firm path to recovery, as evidenced by the continued growth in our business and solid execution, which allowed us to exceed our Q1 revenue and profitability. In the first quarter, we achieved 11% sequential growth in our revenues and 29% sequential improvement in our non-GAAP net income. While certain parts of the demand environment remain somewhat soft, all three of our substrate product lines show the improvement, including a 48% growth in the phosphide revenue from Q4."

Dr. Maurice Young, Chief Executive Officer

"As things are beginning to trend up, we're loosening up some of these constraints, which has brought OpEx up from the previous run rates. We do expect to hold it at approximately this level throughout the rest of this year... With improving demand, we hope to bring our total inventory down by approximately $10 million over the year."

Gary Fisher, Chief Financial Officer

Strategic Positioning

1. AI-Driven Substrate Demand Transformation

AI data center buildout is fundamentally reshaping AXTI’s indium phosphide business, with new customer wins and application breadth. Management highlighted that AI now drives as much as 20% of indium phosphide revenue, with orders increasingly tied to high-speed optical transceivers and next-generation bandwidth requirements. The shift from traditional sulfur-doped to iron-doped (semi-insulating) wafers for AI detectors and lasers marks a notable evolution in substrate mix.

2. Gallium Arsenide and Germanium: Broader Recovery Signals

Sequential growth in gallium arsenide and germanium reflects supply chain normalization and diversified end-market recovery. Gallium arsenide is rebounding in automotive LEDs and power amplifiers, while germanium is recovering in satellite solar, especially in Europe and Asia. Management sees opportunity to gain share in high-power transistor (HPT) applications, with a potential $20 million annual revenue opportunity if traction builds.

3. Operational Leverage and Inventory Strategy

Inventory reduction and cost control remain central to AXTI’s path to profitability. The company targets a $10 million inventory drawdown in 2024, enabled by improved demand visibility and recycling program gains. OPEX discipline is maintained even as growth returns, supporting margin leverage as volume increases. Management’s ability to flex working capital and align cost structure to demand cycles is a strategic strength in volatile markets.

4. China Joint Venture and STAR Market Listing Optionality

AXTI’s partial ownership in over ten China-based supply chain JVs offers both cost advantage and monetization potential. The company continues to pursue a STAR Market listing for its Tongmei subsidiary, with recent progress in addressing regulatory questions. Even if the IPO is delayed, management sees strong investor appetite for minority stakes in its JVs, underlining the strategic value of its China assets.

Key Considerations

AXTI’s Q1 and outlook highlight a business at an inflection, with AI catalyzing demand and operational discipline underpinning recovery. However, customer concentration, visibility limits, and inventory management remain active levers for both upside and risk.

Key Considerations:

  • AI Optical Cycle Acceleration: Indium phosphide demand is being pulled forward by AI data center buildouts, with customer order patterns shortening and new applications emerging.
  • Customer Mix Evolution: A new, large AI customer drove Q1 growth, but the base remains concentrated and subject to order volatility.
  • Inventory and Working Capital Flexibility: The company’s ability to reduce inventory by $10 million is critical for cash generation and margin expansion as demand normalizes.
  • China Asset Monetization: Progress on the STAR Market listing and JV investor interest provide optionality for capital unlocking, even if IPO timing remains uncertain.
  • Legacy Inventory Overhang: Traditional data center and consumer substrate demand is still recovering, with normalization expected by late 2024 or early 2025.

Risks

AXTI faces several key risks: concentrated exposure to a small set of customers, especially in AI and data center verticals; limited order visibility due to shorter lead times and rush orders; and ongoing inventory overhang in legacy substrate channels. Delays or failure in the STAR Market IPO could constrain capital flexibility, though JV monetization provides a partial offset. Geopolitical and regulatory uncertainty in China, as well as potential for rapid demand shifts, remain structural risks to both revenue and margin trajectory.

Forward Outlook

For Q2 2024, AXTI guided to:

  • Revenue between $25.5 million and $27.5 million
  • Non-GAAP net loss of $0.03 to $0.05 per share; GAAP net loss of $0.05 to $0.07

For full-year 2024, management maintained a focus on:

  • OPEX holding steady at current levels
  • Inventory reduction target of $10 million

Management emphasized that gallium arsenide and germanium will drive the next leg of sequential growth, while indium phosphide is expected to be flat in Q2 but could accelerate if additional AI orders materialize. Gross margin is expected to improve modestly with volume and mix, and management reiterated the goal of returning to break-even as early as this year, contingent on revenue scaling to the $28-30 million quarterly range.

Takeaways

AXTI’s Q1 marked a clear pivot, with AI-driven indium phosphide demand and a broadening recovery across substrate lines. Operational execution, inventory discipline, and strategic asset flexibility are setting the stage for margin and cash flow improvement as legacy overhangs clear.

  • AI Inflection Drives Substrate Mix Shift: Indium phosphide’s 48% sequential growth and new customer wins validate the AI optical cycle thesis, with further upside as legacy inventory clears.
  • Operational Leverage Emerging: Cost controls and inventory management provide margin and cash flow optionality as volume recovers, supporting the path to break-even.
  • Watch for Customer Diversification and STAR Listing Progress: Sustained demand across a broader customer set and successful China asset monetization could unlock further value and reduce risk concentration.

Conclusion

AXTI’s Q1 results and outlook confirm that AI-driven demand is catalyzing a fundamental shift in substrate revenue mix and growth trajectory. With operational discipline and inventory flexibility, the business is positioned to benefit from both cyclical recovery and structural tailwinds, though execution on customer diversification and China asset strategy will be critical to sustaining momentum.

Industry Read-Through

AXTI’s results provide a clear read-through for the broader compound semiconductor supply chain: AI data center buildouts are accelerating demand for high-speed optical substrates, pulling forward the adoption curve for indium phosphide and related materials. The shift from legacy consumer and telecom to AI and next-gen photonics is likely to reshape substrate supplier dynamics, benefiting those with scale, cost control, and JV-based raw material access. Inventory management and customer concentration risk will remain key themes for the sector through 2024, with China asset monetization and regulatory navigation increasingly relevant for global players.

AXTI Technology Semiconductors AI Optical Substrates Inventory China